Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
- 30 August 1975
- Vol. 3 (5982) , 511-513
- https://doi.org/10.1136/bmj.3.5982.511
Abstract
Evidence is presented that serum creatinine phosphokinase (CPK) activity is of no direct value in screening patients for susceptibility to malignant hyperpyrexia and does not correlate with halothane-induced muscle contracture or the presence of myopathy. Widely differing CPK values were found at different times in the same people. In most "malignant hyperpyrexia" families the susceptible patients had either normal or inconsistently raised CPK values.Keywords
This publication has 2 references indexed in Scilit:
- Malignant hyperpyrexia myopathy.1973
- Malignant hyperthermia: A statistical reviewCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1970